Sunday, 11 March 2018 17:42

Chem Rev (2017) - CRISPR/Cas9-based genome editing for disease modeling and therapy: opportunities for non-viral delivery

Written by
Rate this item
(25 votes)
Read 1504 times Last modified on Monday, 17 December 2018 06:28
Login to post comments